Eliminating Barriers and Increasing Access to New Testing to Improve Prenatal Care

New advancements can only be fully realized when clinicians, lawmakers, and patients come together. Biomarker tests not only have the potential to improve patient outcomes and address health equity, they can also decrease expenses for financially vulnerable medical systems.  The post Eliminating Barriers and Increasing Access to New Testing to Improve Prenatal Care appeared first…

Read More

Medicaid Work Requirements: Current Waiver and Legislative Activity

With Donald Trump returning to the presidency and Republican control of the Senate and House, work requirements are likely to be back on the agenda—through federal legislation or Medicaid waivers. This issue brief highlights the history of Medicaid work requirements, describes recent state activity to advance work requirement policies, and recaps the landscape of work…

Read More

Washington Power Has Shifted. Here’s How the ACA May Shift, Too.

President-elect Donald Trump’s return to the White House could embolden Republicans who want to weaken or repeal the Affordable Care Act, but implementing such sweeping changes would still require overcoming procedural and political hurdles. Trump, long an ACA opponent, expressed interest during the campaign in retooling the health law. In addition, some high-ranking Republican lawmakers…

Read More

Orion Innovations’ Light-Up Infusion Device Helps Both Patients and Nurses, Research Shows

A Utah-based startup named Orion Innovations released two studies this month demonstrating its product’s efficacy. The device attaches to hospital IV lines and uses a light to assist nurses with the identification and tracing of medication infusion lines, with the goal of reducing errors. The post Orion Innovations’ Light-Up Infusion Device Helps Both Patients and…

Read More

Speculation on RFK Jr. as HHS Secretary

From Tyler Cowen at Marginal Revolution: One of the problems with an RFK Jr. ascendancy is that his core views, which run strongly against vaccines and pharmaceuticals, make it unlikely that any of these reimbursement revisions will be done in a rational or scientific way. The best evidence indicates that pharmaceuticals are a relatively cost-effective ways of saving…

Read More

Startup Valora Unveils a Sweet Way to Stop Cancer and Autoimmune Disease, Plus $30M for R&D

Valora Therapeutics’ antibody lectin chimeras, or AbLecs, target glyco-immune checkpoints, pathways that modulate cellular communication with the immune system. The startup’s science is based on research from Carolyn Bertozzi, a Stanford professor who was awarded the 2022 Nobel Prize in Chemistry. The post Startup Valora Unveils a Sweet Way to Stop Cancer and Autoimmune Disease,…

Read More

Act now for health coverage in 2025

Open Enrollment is now. Start 2025 off right by enrolling in coverage for the new year.  Image For coverage to start: January 1, 2025: Act by December 15, 2024February 1, 2025: Act by January 15, 2025 Make time today for a few easy steps. Coverage may be more affordable and easier than you think.  Apply…

Read More